Does IV heparin after streptokinase prevent left ventricular thrombus in acute anterior myocardial infarction?: a randomised, prospective, double blind, placebo controlled study  by Gehani, A.A. et al.
452A JACC Fehnmry 1998 
Therapy  fo r  Acute Myocardial Thromboly t l c  
Infarction: Clinical Aspects 
Wednesday ,  Apri l  1, i ~,98, Noon-2 :00  p ,m,  
Georg ia  Wor ld  Congress  Center ,  West  Exh ib i t  Hal l  Leve l  
P resentm;on  Hour :  1 :00  p ,m, -2 :00  p.m, 
~ O o e a  IV After Streptoklnsae Prevent Left Heparln 
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Left Vonlrlcular Thrombl~ls (LVT) m a rolnllvcly common and Dotonfinlly son. 
cue complication el Acute Anlerlor Myecardlal Inlamtlon (AAMI), The value 
of hep~rln In prnventlng LVT Is conlmvomlnl, We randomlsed 150 patients 
with first AMI who received Sfraptoklnsso (SK} to either I,V hopann (HEP, N 
.~ 78) or Pin,abe (PLA, N : 72) for 4 days, All patients had e(~ho(~nrdiography 
to ~ssoss the presence of a "deflnttWe" LVT before discharge (5 i 1,3 d~ys), 
APT'[' w~s kept 3--.4 times control In HEP group, ~nd 300 mg Aspmn was 
given dslly to all p~tlents, 
The two groups worn well matched. There was no significant dillemnce 
In the pask CPK (3000 = 2t40 In HEP group va 3100 t 2070 ie PLA grasp, 
p - N,S), or In pro.~K librlnogon (30 t 1,020% le HEP group vs 2,l"t6 I 08B 
in PLA group, p = N,SI Both gro|lp~ showed a dramatic fall In fihtinogen 
loyal pol~t.SK to (0,7 t 0,4 0% and 0,OB t 0,4'/0%, p .  0.001, p - 0.00'1 
ms. l ive ly) ,  
LVT wan found tn 13/7,8 pattnnts who resolved hep~rin (16.6%) vs 10/72 
In PLA group (13,8%), [p = NS, cht.squaro testl, When the whole 0rauP (N 
1501 was analyzed regardless to hopl~rln status, it was folmd that those 
with LVT h~ld n higher peak CPK (3662 t ;~237 U/mr) files those without LVT 
(2954 t ~050 U/mr! 
Conclusion. I.V hoparln after SK does not prevent LV fhrombus format=an 
In AAMI, in fact Ihoro was It slight tendency towards hlgl~or incidence in the 
hoparln group LV thrombus seems to be related mere to t110 size of infarct=on 
ff~f~n to the admtei~tr~tion of hopa~in, A dillolont agent may have to be tried 
0-] Activation of the Contact Pathway In Patients 
Treated With t-PA or Straptokinase may 
Attenuate Clot Lysls 
MP. Lat~cha, WT Schniff. GA, Ewatd, D,R. Abondschoin. P.R. Etsonberg, 
Wtlshmgton Um~rsft), School of Medicine, St, Lou~s. MO. USA 
~ackground' We have shown that activation el the contact system is a 
potential mechamsm for increases in thmmbin activity in patients treated 
with stmptoklnaso (SK) or t-PA. Because thrombin activates plasma procar- 
boxypoptidaso-B (thmmbtn-actlvated fibnnotyGis inhibitor) that acts to atten- 
uate clot lysis, contact activotlon may limit the efficacy of thrombotysm. 
Mofhod~'Results: We measured Xlla concentrations with a novel on- 
zyme.llnked immunosorbont assay based on a specific monoclonal antibody 
In patients tmatnd with 1,500,000 U SK (n = 151 or 100 mg t-PA (n = 121, 
Sixty mlnlltes oltor initiation of the lyric agents, factor Xlla increased from 3.2 
05 to 69  t 08 ng/ml with SK (p = 0,0002), and tram 2.5 t 02 to 6.8 1 
0,9 ng/ml with t-PA (p = 0,0003) Increases in factor Xlla were also induced 
in vitro by incubahon of of SK (250 U/ml) or t-PA (5 ng/ml) with recatcitied 
cttrated plasma, The rate of plasma clot lysis induced by 250 U/ml of SK in 
recalcdied eitrated piasmo was accelerated by 205 :~ 80% with 1 HM himdin 
and 172 i 144% with 2.5 ~M corn trypsin inhibitor (CTI[ a specific factor 
Xlla inhibitor)) (p -: 0.01 vs 11o inhibitor). Acceleration with 2.5 ng/ml t-PA 
was 64 t- 26% with hirudin and 40 t 31% with CTI (p .. 0.01). Inhibition of 
plasma carboxypoptidase actlvlty with a synthetic inhibitor also accelerated 
clot tysis with SK by 189 }; 128%, and 67 ~ 33% with t-PA (p .  0Ot for both, 
compared with no inhibitor). 
Conclusion: Marked lacier XII-dependent activation of the contact system 
ot coagulation occurs ~n paberds treated with fibrinotytic agents, like:), sec- 
ondary to direct activation of factor XII by plasmin, as previously reported. 
Increases in thrombin activity in response to thrombolysis may attenuate the 
rate of clot lysis because of the rapid thrembin-mediated increase in plasma 
carboxypeptidase activity. 
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Pdm~ry (P) PTCA is a logistically demanding theral~utic option; idontifica. 
lion of AMI patients (pie) in whom P-PTCA in moot b~nefiai~l is important 
to optimize both AMI treatment and P.PTCA use, Afit~nor ST depmssmn 
(ASTD) in inferior AMI is ~ marker el poor prognosis, but liffio is known alx~t 
the tong.term mlfoomo o! P.PTCA and t-PA in these pie, One-m0nth m0ults 
from our sttldy in t t0 pfs randomized ta either treatment showed advantages 
of P.PTCA as to now target vessel mvaaou!anzatlon (TVR) (3,6% ~ ;~5.5%, 
p = 0,003), loll vonfnculnr eiection fraction (LVEF) (55% vs 48,%, p = 0.0001), 
TIMI 3 flow at discharge (100% va 59%, p -: 0.0001), and hosl~tal stay (9.2 
vs 12 drlys, p = 0,000t), although combined mortality and re.AM! were not 
signlf!(~ant!y different (36 vs t 1%, p = no). 
We present the long.term results on mortality and non.fatal m-AMI, need 
tot TVR, and hospital madmis~ion on all 106 pts d i scha~ aliv0 allot ran, 
dami-..ed tloatment with P.PTCA (54 pts) and accelerated t.PA (52 pts), 50% 
of eta el each gloup had multi.vessel disease, At a mean follow-up of 182 
t 0.7 mon)hs no diltemnco was obsewod In tem~s of mortality and re-AMI 
(1 it'~,, VS 1.3%, p = as). The need for WR was lower in the P.PTCA group 
(1 8%, va 17%, p = 0,01), as WaS the incidence of new hospaat admass~ons 
(5,5% vs 40%, p = 0,0001 ). Using Kap!rm.Mmer curves for event.free anatys=s 
(non-lschomlc oaKlla¢ ovoefs and efo¢tlvo mvas~ulanzat~n were included 
In the analysts), patients randomly assigned to P.PTCA had a stgnilmantty 
bettor evont-tm~ sun/Ival (log. rank 162, p - 0.00011, with no dllfemnco m 
mndNity (log. rank 1.4, p = ns). 
Conclusion: suponor rosuffs m pts randomized to P.PTCA. as seen at 
one-month pomist at loop.term, with tower TVR and hospital roadmcss~ons. 
Mortality end rolnfalction rates mmam equivalent troth either treatment at 
long-term tollow.up; thin is probably the effect el the high rate el reperlusmn 
oblained by both treatments m ouw cohort el pts, as tellected by a presen~l 
LVEF ot discharge, and el extensive subseduent use of new revasculanzal~on 
procedures (both u~gont and etoctlvo), specially In pts wrth mmaf thrombolysm 
1 87-152 1 Bedside Lyric Activity Assessment During 1 
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Et~'~ckground Accelerated infusion of tPA (Ace tPA) ts considered as the most 
ellechve thrombolyhc regimen m AMI (Gusto I thai) TNK-tPA Is a new tPA 
mutant suggested to be more fibnn specific, more resistant to PAl.t. and ot 
longer hall-lifo given as a single IV bolus under ctimcal evaluation. 
Methods: To coml~aro the lyric activity (L Act) induced by Acc tPA and 
TNK-tPA (30 or 40 mg). lysis onset time (LOT) of a trash autoIogous thrombus 
was determined ox-vivo using a bedside thrombolytic assessment system 
(TAS", CVDI, USA) at basehno, 10, 60, 90 and 180 rain tn 80 AMI pts. 6'1 
treated with ACC tPA and 19 with TNK-tPA L Act is pmpodionato to shortening 
o! LOT. absent when LOT - 1200 sac. The lyric reserve (LR) was assessed 
by the LOT response to 1000 U/ml tPA in vitro at basehne and 180 rain. 
Resuffs: LOT doten'ninahons are expressed as median (in seconds); 
Basehne 10 mm 60 rain 90 mm 180 m=n 
LOT- IPA - 1200 138 169 .1200 
LAct TNK-tPA .1200 111" 192 328' 1139- 
LOT- tPA 103 - 116 ~ 
LFI TNK-IPA 118 - 121 
*p • 0 so01, "'p = 0045 vs tPA: ~'p - 0 012 v$ basehne 
Conclusions: 1 ) The TNK-tPA bolus (30 or 40 rag) induces a more intense 
immediate tytic response than 15 mg tPA bolus. This activity weans gradually 
keeping some L Act at 3 hours, by contrast the tPA infusion maintains the 
established L Act (with the same intensity) for 90 rain followed by rapid 
weaning IPaving no actwity at 3 hours. 2) Unlike tPA, TNK-tPA does not 
impaire the lyric reserve reflecting further enhancement of fibrin specificity. 
